Filing Details

Accession Number:
0001288123-10-000011
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2010-01-22 12:00:00
Reporting Period:
2010-01-19
Filing Date:
2010-01-22
Accepted Time:
2010-01-22 14:20:51
Original Submission Date:
2010-01-21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098972 Antigenics Inc AGEN Biological Products, (No Disgnostic Substances) (2836) 061562417
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1437152 Karen Valentine C/O Antigenics Inc.
3 Forbes Rd
Lexington MA 02421
Vp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-19 93,789 $0.90 174,319 No 4 A Direct
Common Stock Disposition 2010-01-20 93,789 $0.85 80,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents settlement of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance.
  2. Represents the sale of shares obtained from the vesting of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.
  3. This amended filing is made to properly reflect the shares as disposed. These shares were obtained from the vesting of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.